Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pure Med Farma funding hits...then they are funding Regenicin.
This stock and company are a steaming pile of crap. Ridiculous to not announce anything and release a quarterly. I'm chalking this one up as a loss at this point.
I think they did have a go at pump and dump. Falsely claiming that the FDA IND status conferred some kind of approval on them. But also this was when the Discala indictment was getting sorted, and all sorts of people peripheral to this outfit were in the gun. As you can see above - some Discala related entities remain showing as shareholders, that might be historic but if form is any guide, probably not.
But yeah - buyer be very aware indeed.....
It has to be a skim because it certainly isn't a pump and dump. I got caught up in one of those. Anybody remember NSCT?
Buyer beware I think is what Skept is getting around to. I can sincerely say zero results would not last more than 18 months in a legit boardroom let alone any publicly held c-corp or LLC. This has been diliberately set up to skim. Period. 10 years and zero results . Please you must be kidding
Configman - I've had a fair bit of dough in this, but a fair while ago, I got into it on rumour and out of it when I did some proper DD on McCoy and his mates, and made the connections with the Discala indictment and various other shady entities. Plus I have a contact in New Zeeland who keeps up to date with what is going on down there. I do have some involvement with other firms in this space. So my main interest is in keeping an eye on this and suggesting people do some DD before spending anything on McCoy entities.
History will show RGIN always files late and always runs out the clock in announcing.
What difference does it make, there is nothing here or pretty much ever.
Fatboy McCoy has been ripping off shareholders for years, just ask any Windstar shareholder.
Quarterly report was due 11/14.No report filed and no form for extension filed.This may move to grey sheet for not filing report.Sad.
Skept. Just what is your position here. Are you an investor in RGIN or are you here to save from us from this terrible fraud.
Oh we will hear something all right. It will be the same as what we have heard for years. This time instead of the Middle East, I predict that the new great project will be in Africa, where billions of dollars will be made and thousands of people will be employed working on McCoy ideas.
Or was that 2015?
The only thing we can be sure of is that none of what we are told by RGIN will be true.
So I guess the quarterly is due this week? Maybe we hear something, anything from this crappy company...
Yes, wait a few more weeks, because the last 8 years have not been any guide to how fantastic the new few weeks will be. The rainbow is only just over the horizon.
Same we can't do polls on this site, to see how many would believe anything to do with this shady outfit. Excluding Nicole/McCoy, and the other two McCoy personas.
I expect a post any minute to advise how well the people who stick in there are going to do, making their fortunes from those who exited etc etc. Again.
Lets see what happens in next few weeks
The last time there was a reasonable PR was a few years back when RGIN mis worded a press release to indicate they'd receive FDA approvals, the sp popped to .64 cents, that was the last glimmer of hope for this company after fatboy McCoy was run out of New Zealand
Now he seeking undisclosed shieks of Arabia to fund this cluster while making the neede collagen from Camel balls
whats not to love about this jackass
Seems like its a game of chicken....50,000 to be exact lol
Not sure if this refers to the fact that McCoy is an ex Navy guy turned lab techie. I.e. not any sort of professor etc. Or maybe it is referring to the entities he is associated with, which don't bear too much scrutiny. Or perhaps I'm missing something, but overall - when you look at this thing or that guy very closely, you will soon agree with Apples conclusion.
Can you guys explain what you see in that link that makes him a scumbag? Not understanding.
Pretty sure that this confirms my previous allegations.
What a absolute scumbag
I see that people here are referring to McCoy as a Professor. He did work for Universities as a Tech/lab guy, but I think the only thing he has high level qualifications in is snowjobs. A professor in handling the truth carelessley maybe.
Look at the filings, RGIN doesnt announce anything because there arent any successes with this company.
Management doesnt care about retail. McCoy eats any profits, literally have you ever seen the size of this clown?
Overweight, Diabetic suffers from Edema Fluid retention and HBP, who knows what else.
He'll be dead before this collagen fantasy ever grows a thumb.
Total SCAM since the Windstar days
This stock looks to be in bad shape. Guess when you don't announce news for almost 2 years that's what happens. Starting to agree with skept and apple that this is a scam. Praying for some news so i can get out with my ass still attached.
Scotttrader - that camel semen info has way more credibility and is far more likely than anything said by Nicole/Randall McCoy. Had a look at the link. Classic McCoy. "Hundreds of products" and "thousands of lives" and shows "new facilities" (non-existent of course - standard) blah blah blah. Complete fantasy and fabrication. But hey - who is surprised?
This whole thing was a good thought to begin under Windstar. Unfortunately we're 11 years out. This tech has been superceded by other companies and vendors that are far ahead of this nonsense. There's surgical Band-Aids and wound coverings that report via wireless on the condition and administer medication to the wound wirelessly via imbedded heat release. At the discrection of the Doctor or RN at the touch of a hot key on their active screen from any location. With high levels of balance when or when medication is not needed or may be necessary.
McCoy again is a college professor. Knows nothing about real world and welcome to the rabbit hole he dragged you down. This whole scam needs to crash. Shut down and he needs to figure out how to support himself like an actual person. Not mention he's 70+ years old. He's the only one selling. Just paying his bills and free cash. What a joke.
That link doesnt work, but Yeah, McCoy is the head kahuna at RGIN who is supposedly talking with Saudi Investors now to develop the collagen from Camel sperm.
I will admit, the lack of news for well over a year is extremely disturbing. I have heard it through the grapevine, just like huntsman, that things aren't dead and slowly moving along. I'll admit, I'm just here for an play on funding announcement and hopefully a 2nd trade on FDA go ahead to start trials. Hopefully with news on those 2 fronts there will be an opportunity to trade this for some decent profit.
I think that was the idea Hans, but that was 18 months ago. If you google that company for public information and then look at the people involved, doesn't look very inspiring. And I still don't get why we think that reginicin will have top secret valuable IP, for all this time, battling away with no cash and millions accrued liabilities, which by their own admission is 10+ years old now. How likely is that?
It seems to me that with the formation of this australian pacific life sciences company in May of 2017, one would think that things are moving along. I was informed that this company would be supplying RGIN when they hopefully move forward with their trials.
There are a couple broken relationships, this is true. However the original players are still on board and the project is still moving forward. Unfortunately there is no definitive time table as I have said before. Slow forward is better than stopped.
Not what I've heard Huntman... McCoy still claims to be in partnership with people that never want to see him again apparently. There are always promises that things are progressing - great things are "just about here" and the company IP is about to be discovered for the faithful blah blah. bu nothing ever actually happens except the web of interrelated McCoy companies continue to deceive.
Closed herd did not fall through in New Zealand or Australia either, both are alive and moving forward, although slowly.
Hi guys. Been lurking for a while. Came across this company that has rgin listed as a partner and MCCOY has his hands all over. Is this the resurrection of the new zealand closed herd thing? Thoughts?
[url][/url][tag]https://www.auspaclifesciences.com/[/tag]
hi guys long time lurker. Any thoughts on this company? Reginicin is listed as a partner and MCCoy looks to be heavily involved. Is this the closed herd thing that fell through in New Zealand? Thoughts?
[url][/url][tag]https://www.auspaclifesciences.com/[/tag]
You obviously do not have the current status updates.....
More volume at 3.3c.....
Nicole/Randall - surely the Saudi money has come through? It's been on the cards for years and years? Let me guess - it is very close now? What about the 10 year old "ground breaking" research and IP? Surely J&J will discover us soon and we will make heaps?
What about all the other "great things" that have been just over the horizon, and imminent - for years, are any of those coming home soon?
Or is this whole thing a complete crock?
That would apply to the prior day trades on the day it was posted. Your at .03
13,500...not much of an exodus
To each is thier duty of diligence when in vesting. Obtaining a loan. Driving a car. Walking down the street
. Just warning all sucked into this sinkhole that I gave you sufficient warning.
Yep, if the investment is "gambling" money, may as well see what happens. Watch Randall spin the roulette wheel some more, and hope he doesn't have his knee on the button under the table...... Roll up, roll up, get your snake oil here.
Possibly, time will tell. Like I said before how much more is there to really lose? Might as well hang on.
I think applevision is more likely right. Someone on here said recently that Discala companies hadn't been shareholders. If you look a page or 2 up from this board you will see Broadsmoor and PDA Assoc - both using the adress of 560 Lexington and both Discala associated.
How many years have they been saying some variation of "hold on - salvation is coming" for? Quite a few. OK there may not be any visible fire, but there is one hell of a lot of smoke pouring out of this outfit.
Applevision, you have the right to stay in or get out as you see fit. Going by your posts you have chosen to get out. This choice will prove to be either smarter or dumber than our choice to stay in, only time will tell. I caution you to be careful mistaking patience for stupidity, remember the story about the tortoise and the hare.
Just curious, anyone ever tell you that your style sucks? Google AXXHOLE.
Nobody can be that nieve or uniformed. Google Windstar. Prior criminal outfit. Now it's RGIN. Geriatric tech that's been surpassed. Holdings are worthless.
Followers
|
71
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2933
|
Created
|
08/06/10
|
Type
|
Free
|
Moderators |
Regenicin, Inc.
10 High Court
Little Falls, NJ 07424
**updated and correct phone number** (973) 557-8914
they filed this on aug 22 2016- http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11558959
Name: | Randall McCoy |
Title: | Principal Executive Officer and Director |
Date: | August 22, 2016 |
Name: | John J. Weber |
Title: | Principal Financial Officer and Director |
Date: | August 22, 2016 |
LITTLE FALLS, N.J., June 12, 2012 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that the Food and Drug Administration (FDA) has granted Orphan Status approval for the PermaDerm® product, the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers, that is indicated for catastrophic burn patients. The FDA had previously designated PermaDerm® to be a biological/drug (permanent skin replacement) not a medical device (temporary skin replacement). PermaDerm® is the only skin replacement technology to receive this Biological/drug designation.
COMPANY HIGHLIGHTS:
PermaDerm™ is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days.
These living, self-to-self skin graft tissue are intended to form permanent skin tissue that will not be rejected by the immune system of the patient, a critical possibility in porcine or cadaver skin grafts used today.
The technology has been clinically tested in over 150 pediatric, catastrophic burn patients. Currently Regenicin is working with its contract manufacturer to prepare for pre-market approval of PermaDerm™ from the FDA.
PermaDerm™ is being designed to save lives, reduce healthcare costs by decreasing the patient's stay in the Critical Care Unit and reduce the need for additional surgeries. An insurance company procedural code has been approved for reimbursement of costs to hospitals. The American Medical Association has assigned CPT (Current Procedural Terminology) code for cultured skin substitutes under the dermal substitute category which enables insurance companies to process and hospitals to be reimbursed for cultured skin substitutes once approved by the FDA.
According to the American Burn Association, there are currently over 2,000 cases annually involving burns covering over 50% of the patient's total body surface area.
PermaDerm™ is being developed for the treatment of catastrophic, full-thickness burns covering over 50% of the total body surface area.
PermaDerm™ has been used in clinical trials on pediatric patients with catastrophic burns covering from 50 to 90+% of their body.
PermaDerm™ is being developed to require less donor skin from the patient's own body, thus needing fewer surgeries to harvest skin. The result is expected to be less scarring, with fewer infections and faster healing.
Randall McCoy
Chief Executive Officer
Randall McCoy has more than 37 years of experience in the healthcare industry. His experience includes executive positions and scientific research and development. His previous employment includes George Washington University, Temple University Medical School and RCA/SRI International (Director of Life Sciences and Electronic Displays). Mr. McCoy has assisted both small and major pharmaceutical/device companies address FDA issues. He has also helped over 225 foreign and domestic companies introduce their FDA regulated drug and medical device products into the US and World market. Mr. McCoy currently has over 30 Patents US and International.
Changed to AMBS
Dr. Joseph Rubinfeld Ph.D
Director at CytRX; Initial Co-Founder of Amgen, Inc.
Dr. Joseph Rubinfeld co-founded SuperGen, Inc. in 1991 and has served as its Chief Executive Officer and President, Chief Scientific Officer and as a director. He has been a director of CytRX since July 2002. Dr. Rubinfeld is also a founder of JJ Pharma. Dr. Rubinfeld was one of the four initial founders of Amgen, Inc. in 1980 and served as a Vice President and its Chief of Operations until 1983. From 1987 until 1990, Dr. Rubinfeld was a Senior Director at Cetus Corporation and from 1968 to 1980, Dr. Rubinfeld was employed at Bristol-Myers Company. Dr. Rubinfeld received a B.S. degree in chemistry from C.C.N.Y. and an M.A. and Ph.D in chemistry from Columbia University.
John Weber
Regenicin™'s Interim CFO
John Weber most recently served as Executive Vice President of Fujifilm USA, the highest ranked American corporate officer, from 2006 until his departure in 2009. His responsibilities included overseeing all corporate activity with the exception of R&D. During that time Fujifilm was ranked as the fastest growing medical imaging company, consistently ranking #1 or #2 in customer satisfaction. From 1998 through 2006 he served as Senior Vice President, Operations at Fujifilm USA where he spearheaded the transition of the company from a film distributor to a digital medical informatics company. From 1986 until 1998 he served as CFO where he helped to profitably manage Fuji's growth from an employee base of 75 to over 1,000. Prior to his distinguished career at Fujifilm USA, Mr. Weber served as the CFO for the confectionary and drinks division of Cadbury Schweppes Limited for three years and as Corporate Controller for an additional five years.
Dr. Craig Eagle
Pfizer Oncology
Dr. Craig Eagle joined Pfizer Australia in 2001 as part of the medical group. In Australia, his role involved leading and participating in scientific research, regulatory and pricing & re-imbursement negotiations for compounds in therapeutic areas including oncology, anti-infectives, respiratory, arthritis and pain management. In 2003, Pfizer relocated Dr. Eagle to the United States where he was appointed as the worldwide lead for development of Celecoxib in oncology to oversee the global research program. Since that time he has had increasing responsibility for overseeing the global research plans and teams for Irinotecan and Dalteparin. In 2007, he became head of Medical Affairs and Outcomes Research for Pfizer, including the US oncology business. Dr. Eagle has led, or been directly involved with, teams that resulted in eight new products or indications. As part of his current role at Pfizer, he has led the integration of the Pfizer/Wyeth oncology businesses and portfolio.
The Broadsmoore Group, LLC 9,223,770(8)
560 Lexington Ave., 16 th Fl.
New York, NY 10022
PDA Associates LLC 7,770,000(9)
560 Lexington Ave., 16 th Fl.
New York, NY 10022
Officers, directors and 5 percent shareholders collectively 54,508,099(10) 59.74%
* Less than 1%
(1) Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power (or shares that power with that person's spouse) with respect to all shares of common stock listed as owned by that person or entity.
(2) A total of 83,807,964 shares of the Company's common stock are considered to be outstanding pursuant to Rule 13d-3(d)(1) under the Securities Exchange Act of 1934.
(3) Includes 32,821,641 shares of common stock held in his name and options to purchase 885,672 shares of common stock.
(4) Includes 50,000 shares of common stock held in his name and options to purchase 885,672 shares of common stock,
(5) Includes 1,050,000 shares of common stock held in his name and options to purchase 885,672 shares of common stock
(6) Includes 50,000 shares of common stock held in his name and options to purchase 885,672 shares of common stock,
(7) Includes 33,971,641 shares of common stock, options to purchase 3,542,688 shares of common stock and shares of Series A Convertible Preferred Stock convertible into 3,350,000 shares of common stock,
(8) Includes 5,706,270 shares of common stock held in its name, warrants to purchase 167,500 shares of common stock and shares of Series A Convertible Preferred Stock convertible into 3,350,000 shares of common stock,
(9) Includes 7,400,000 shares of common stock held in its name and warrants to purchase 370,000 shares of common stock,
(10) Includes 47,077,911 shares of common stock, warrants to purchase 537,500 shares of common stock, options to purchase 3,542,688 shares of common stock and shares of Series A Convertible Preferred Stock convertible into 3,350,000 shares of common stock
http://ih.advfn.com/p.php?pid=nmona&article=5144097
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |